Xeris Biopharma Holdings Inc (NASDAQ: XERS): Do Not Miss The Gain Train

Xeris Biopharma Holdings Inc (XERS) concluded trading on Thursday at a closing price of $5.16, with 5.21 million shares of worth about $26.88 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 60.25% during that period and on May 08, 2025 the price saw […]

Is Xeris Biopharma Holdings Inc (NASDAQ: XERS) Proving The Doubters Wrong?

BlackRock Fund Advisors has recently announced that it has increased stake in Xeris Biopharma Holdings Inc (NASDAQ:XERS) by 0.67%. After grabbing 8.4 million shares, the institutional investor is now in possession of 56076.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 6.08% having worth around $15.63 million. Moreover, […]

Is Xeris Biopharma Holdings Inc (NASDAQ: XERS) Proving The Doubters Wrong?

BlackRock Fund Advisors has recently announced that it has increased stake in Xeris Biopharma Holdings Inc (NASDAQ:XERS) by 0.67%. After grabbing 8.4 million shares, the institutional investor is now in possession of 56076.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 6.08% having worth around $15.63 million. Moreover, […]

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.